24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
23andMe
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
20:40
Blue-and-white Black Hat: How Israel came to dominate cyber's biggest conference
19:46
Base44 founder Maor Shlomo launches cancer research fund after losing his mother to the disease
18:27
Israeli chip company Xsight Labs raises $300 million at $2.8 billion valuation
16:52
“We are prepared to be very aggressive”: Check Point signals appetite for a major cyber acquisition
More stories
Buzz
Most popular
Daily
Weekly
1
ServiceNow continues layoffs as it restructures around AI
2
“We want to replace Datadog”: groundcover raises $100 million at $500 million valuation as AI reshapes observability
3
AI security startup Onyx raises $113 million Series B at $640 million valuation
4
Cyber unicorn Cyera acquires Oasis Security in $1 billion deal
5
Jared Kushner’s Affinity Partners sells $343 million Phoenix stake after fivefold return
More news
23andMe
3 stories about 23andMe
23andMe’s downfall: From $3.5 billion IPO to bankruptcy filing
24.03.25
|
CTech and Reuters
A court-supervised sale is now the company’s best hope for the future.
CTech’s top 10 stories of 2024: A year in Israeli high-tech
01.01.25
|
CTech
The most-read articles this year reveal the triumphs, turmoil, and transformations shaping Israel’s tech landscape.
23andMe’s promise of genetic testing has been shattered
06.06.24
|
Viki Auslender
Three years have passed since the IPO of genetic testing company 23andMe and it has faced a nosedive in profits due to public mistrust, a one-time use product, ethical concerns about user data, and security breaches